XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Income Taxes    
Income Taxes

Note 18 — Income Taxes

During the three months ended March 31, 2021, the Company recorded no income tax benefits for the net operating losses incurred in the period due to its uncertainty of realizing a benefit from those items. All of the Company’s operating losses since inception have been generated in the United States.

The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company’s history of cumulative net losses incurred since inception through March 31, 2021 and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Management reevaluates the positive and negative evidence at each reporting period. As of March 31, 2021 and December 31, 2020, no facts or circumstances arose that affected the Company’s determination as to the full valuation allowance established against the net deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of March 31, 2021 and December 31, 2020.

Note 21 — Income Taxes

The Company’s income tax expense consisted of the following for the years ended December 31, 2020, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

Current Income Tax Expense:

 

 

  

 

 

  

 

 

  

Federal

 

$

 —

 

$

 —

 

$

 —

State and local

 

 

10

 

 

11

 

 

 3

Total Current Income Tax Expense

 

 

10

 

 

11

 

 

 3

Deferred Income Tax Expense:

 

 

  

 

 

  

 

 

  

Federal

 

 

 —

 

 

 —

 

 

 —

State and local

 

 

 —

 

 

 —

 

 

 —

Total Income Tax Expense

 

$

10

 

$

11

 

$

 3

 

Deferred income taxes are recorded using enacted tax rates based upon differences between financial statement and tax bases of assets and liabilities. The significant components of the Company’s estimated deferred tax assets and liabilities as of December 31, 2020 and 2019 are as follows:

 

 

 

 

 

 

 

 

    

2020

    

2019

Deferred Tax Assets:

 

 

  

 

 

  

Net operating losses

 

$

7,042

 

$

5,881

Accrued expenses

 

 

109

 

 

Unearned premiums

 

 

466

 

 

Contract expense

 

 

332

 

 

262

Intangible assets

 

 

204

 

 

Other

 

 

406

 

 

809

Total deferred tax assets

 

 

8,559

 

 

6,952

Less: valuation allowance

 

 

(8,559)

 

 

(6,910)

Net Deferred Tax Assets

 

 

 —

 

 

42

Deferred Tax Liabilities

 

 

 

 

 

 

Fixed assets

 

 

 —

 

 

(42)

Total deferred tax liabilities

 

 

 —

 

 

(42)

Net Deferred Tax Liabilities

 

 

 —

 

 

(42)

Net Deferred Tax Assets/Liabilities

 

$

 —

 

$

 —

 

A valuation allowance has been established for all deferred tax assets because the Company has incurred cumulative losses in recent years and the Company has not determined that the net deferred tax assets are more likely than not to be realized. In future periods, if the Company determines it is more likely than not that the deferred tax assets will be realized, the valuation allowance may be reduced and an income tax benefit recorded. The following table presents the change in the deferred tax asset valuation allowance for the years ended December 31, 2020, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

January 1,

 

$

6,910

 

$

3,986

 

$

2,008

Additions – Charged

 

 

1,649

 

 

2,924

 

 

1,731

Deductions – Charged

 

 

 —

 

 

 —

 

 

 —

Other

 

 

 —

 

 

 —

 

 

247

December 31,

 

$

8,559

 

$

6,910

 

$

3,986

 

As of December 31, 2020, the Company has Federal net operating loss carryforwards of approximately $29,200, of which $6,400 will expire at various dates from 2031 – 2038 and $22,800 will carryforward indefinitely but can only be used up to 80.00% of taxable income. The Company has state net operating loss carryforwards of approximately $22,100, which will expire at various dates from 2031 — 2038. Certain tax attributes of the net operating loss carryforwards may be subject to an annual limitation as a result of a change of ownership in prior years as defined under Internal Revenue Code Section 382.

The differences between income tax benefit expected at the U.S. federal statutory income tax rates of 21.00% (for 2020 and 2019) and 35.00% (for 2018) and the reported income tax expense are summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

 

Loss Before Income Tax Expense

 

$

(6,542)

 

$

(12,667)

 

$

(6,557)

 

Income tax benefit at federal statutory rates

 

 

(1,372)

 

 

(2,660)

 

 

(1,377)

 

State and local income taxes

 

 

(79)

 

 

(471)

 

 

(238)

 

Investment remeasurement

 

 

 —

 

 

 —

 

 

(126)

 

Valuation allowances

 

 

1,649

 

 

2,924

 

 

1,731

 

Change in fair value of redeemable convertible preferred stock tranche obligation

 

 

(194)

 

 

293

 

 

57

 

Other

 

 

 6

 

 

(75)

 

 

(44)

 

Total Income Tax Expense

 

$

10

 

$

11

 

$

 3

 

Effective Tax Rate

 

 

(0.15)

%  

 

(0.09)

%  

 

(0.05)

%

 

Income tax returns are filed in the U.S., including multiple state jurisdictions, and are subject to examination by tax authorities in the jurisdictions where the Company operates. The Company has open tax years from 2018 to 2020. The Company has determined that it does not have any unrecognized tax benefits or obligations as of December 31, 2020 and 2019.